搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Vibrio cholerae serotype O1 tRNA pseudouridine synthase C (truC) CSB-YP873163VEX
CSB-EP873163VEX
CSB-BP873163VEX
CSB-MP873163VEX
CSB-EP873163VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Citrate lyase acyl carrier protein (citD) CSB-YP873164VEX
CSB-EP873164VEX
CSB-BP873164VEX
CSB-MP873164VEX
CSB-EP873164VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Nucleoside diphosphate kinase (ndk) CSB-YP873165VEX
CSB-EP873165VEX
CSB-BP873165VEX
CSB-MP873165VEX
CSB-EP873165VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) CSB-YP873166VEX
CSB-EP873166VEX
CSB-BP873166VEX
CSB-MP873166VEX
CSB-EP873166VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Recombination-associated protein RdgC (rdgC) CSB-YP873167VEX
CSB-EP873167VEX
CSB-BP873167VEX
CSB-MP873167VEX
CSB-EP873167VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Trp operon repressor homolog (trpR) CSB-YP873168VEX
CSB-EP873168VEX
CSB-BP873168VEX
CSB-MP873168VEX
CSB-EP873168VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Isoleucine--tRNA ligase (ileS), partial CSB-YP873169VEX
CSB-EP873169VEX
CSB-BP873169VEX
CSB-MP873169VEX
CSB-EP873169VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 tRNA pseudouridine synthase B (truB) CSB-YP873170VEX
CSB-EP873170VEX
CSB-BP873170VEX
CSB-MP873170VEX
CSB-EP873170VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Transcription elongation factor GreA (greA) CSB-YP873171VEX
CSB-EP873171VEX
CSB-BP873171VEX
CSB-MP873171VEX
CSB-EP873171VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Glutamyl-Q tRNA (Asp) synthetase (gluQ) CSB-YP873172VEX
CSB-EP873172VEX
CSB-BP873172VEX
CSB-MP873172VEX
CSB-EP873172VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 50S ribosomal protein L13 (rplM) CSB-YP873173VEX
CSB-EP873173VEX
CSB-BP873173VEX
CSB-MP873173VEX
CSB-EP873173VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Probable oxaloacetate decarboxylase gamma chain 1 (oadG1), partial CSB-YP873174VEX1
CSB-EP873174VEX1
CSB-BP873174VEX1
CSB-MP873174VEX1
CSB-EP873174VEX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 tRNA pseudouridine synthase D (truD) CSB-YP873175VEX
CSB-EP873175VEX
CSB-BP873175VEX
CSB-MP873175VEX
CSB-EP873175VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Undecaprenyl-diphosphatase (uppP), partial CSB-YP873176VEX
CSB-EP873176VEX
CSB-BP873176VEX
CSB-MP873176VEX
CSB-EP873176VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 UPF0301 protein VC_0467 (VC_0467) CSB-YP873177VEX
CSB-EP873177VEX
CSB-BP873177VEX
CSB-MP873177VEX
CSB-EP873177VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 UPF0001 protein VC_0461 (VC_0461) CSB-YP873178VEX
CSB-EP873178VEX
CSB-BP873178VEX
CSB-MP873178VEX
CSB-EP873178VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Chaperone surA (surA) CSB-YP873179VEX
CSB-EP873179VEX
CSB-BP873179VEX
CSB-MP873179VEX
CSB-EP873179VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Maf-like protein VC_0418 (VC_0418) CSB-YP873180VEX
CSB-EP873180VEX
CSB-BP873180VEX
CSB-MP873180VEX
CSB-EP873180VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Protein TusC homolog (tusC) CSB-YP873181VEX
CSB-EP873181VEX
CSB-BP873181VEX
CSB-MP873181VEX
CSB-EP873181VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 DNA mismatch repair protein mutL (mutL), partial CSB-YP873182VEX
CSB-EP873182VEX
CSB-BP873182VEX
CSB-MP873182VEX
CSB-EP873182VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>